Details for New Drug Application (NDA): 202160
✉ Email this page to a colleague
NDA 202160 describes OXYCODONE HYDROCHLORIDE, which is a drug marketed by Ani Pharms, Avanthi Inc, Dr Reddys Labs Sa, Genus Lifesciences, Lannett Co Inc, Novel Labs Inc, Abhai Llc, Alkem Labs Ltd, Ascent Pharms Inc, Aurolife Pharma Llc, Chartwell Molecular, Hikma, Pharm Assoc, Quagen, Rhodes Pharms, Specgx Llc, Vistapharm, Vistapharm Llc, Wes Pharma Inc, Xttrium Labs Inc, Actavis Elizabeth, Alvogen, Amneal Pharms, Epic Pharma Llc, Nesher Pharms, Nuvo Pharm, Strides Pharma, Sun Pharm Inds Inc, Endo Operations, Barr Labs Inc, and Watson Labs, and is included in fifty-one NDAs. It is available from thirty-eight suppliers. Additional details are available on the OXYCODONE HYDROCHLORIDE profile page.
The generic ingredient in OXYCODONE HYDROCHLORIDE is ibuprofen; oxycodone hydrochloride. There are sixty-four drug master file entries for this compound. Additional details are available on the ibuprofen; oxycodone hydrochloride profile page.
The generic ingredient in OXYCODONE HYDROCHLORIDE is ibuprofen; oxycodone hydrochloride. There are sixty-four drug master file entries for this compound. Additional details are available on the ibuprofen; oxycodone hydrochloride profile page.
Summary for 202160
| Tradename: | OXYCODONE HYDROCHLORIDE |
| Applicant: | Aurolife Pharma Llc |
| Ingredient: | oxycodone hydrochloride |
| Patents: | 0 |
Pharmacology for NDA: 202160
| Mechanism of Action | Full Opioid Agonists |
Suppliers and Packaging for NDA: 202160
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| OXYCODONE HYDROCHLORIDE | oxycodone hydrochloride | TABLET;ORAL | 202160 | ANDA | Aurolife Pharma, LLC | 13107-055 | 13107-055-01 | 100 TABLET in 1 BOTTLE (13107-055-01) |
| OXYCODONE HYDROCHLORIDE | oxycodone hydrochloride | TABLET;ORAL | 202160 | ANDA | Aurolife Pharma, LLC | 13107-055 | 13107-055-30 | 30 TABLET in 1 BOTTLE (13107-055-30) |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 5MG | ||||
| Approval Date: | Nov 19, 2012 | TE: | AB | RLD: | No | ||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 15MG | ||||
| Approval Date: | Nov 19, 2012 | TE: | AB | RLD: | No | ||||
Profile for product number 003
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 30MG | ||||
| Approval Date: | Nov 19, 2012 | TE: | AB | RLD: | No | ||||
Complete Access Available with Subscription
